RIMAG GROUP (02522) Strategic Upgrade Defined by Wang Shihe: "Scene+Data+AI" Framework Charts Unique Path in Medical Imaging

Stock News04-28 14:25

At the RIMAG GROUP (02522) Strategic Upgrade and Global Digital-Intelligent Imaging⁺ Ecosystem Conference held on April 28th, group founder Wang Shihe clearly outlined in his strategic summary that RIMAG GROUP's unique advantage lies in the complete closed loop of "Scene + Data + AI," which also constitutes a core barrier that others "can understand but cannot replicate." He emphasized that RIMAG GROUP's move is not a sudden, whimsical transformation but stems from a four-step strategy established back in 2016: "building centers – operational standardization – data services – ecosystem incubation." It is a decade of persistence that has brought them to this point. Wang Shihe further pointed out that medical imaging AI is progressing from the era of 1.0 single diseases and the 2.0 era of single body parts with multiple diseases, towards the 3.0 era of Artificial General Intelligence (AGI) in medical imaging. With the "Hetu Plan" as its foundation, RIMAG GROUP is driving an industrial leap from base models to batch intelligence manufacturing, truly realizing the "AIDIY" technological paradigm. At the conference, RIMAG GROUP, in collaboration with leading hospitals including Beijing Tiantan Hospital affiliated with Capital Medical University, Beijing Anzhen Hospital affiliated with Capital Medical University, West China Hospital of Sichuan University, The First Affiliated Hospital of Nanchang University, and Obstetrics and Gynecology Hospital of Fudan University, jointly launched the "Medical Imaging Digital Twin AIDIY Scientific Research Cooperation Plan." This initiative will focus on the joint research and development of super-intelligent agents for areas including the craniocerebral region, thoracoabdominal region, head and neck, and bones and joints. Wang Shihe indicated that RIMAG GROUP's moat is precisely the "AIDIY technology paradigm"沉淀ed in real-world scenarios—empowering the doctors who best understand imaging to lead R&D, prioritizing data standardization as the number one project, and achieving the industrial transition from base models to batch intelligence manufacturing. "First, define the future; then, create it," Wang Shihe stated. "RIMAG GROUP's goal is to become the global leader in the digital-intelligent imaging⁺ ecosystem."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment